The effects of dehydroepiandrosterone on sexual function: a systematic review

References

• Almeida PH, Castro FCD, Kurizky PS, Muniz LF, Mota LM. How the rheumatologist can guide the patient with rheumatoid arthritis on sexual function. Rev Bras Reumatol 2015;55:458–63
   PubMed Web of Science ®Google Scholar
• Abdo CH. Development and validation of the male sexual quotient – a questionnaire to assess male sexual satisfaction. Rev Bras Med 2006;63:42–6
   Google Scholar
• Abdo CH, Fleury HJ. Diagnostic and therapeutic aspects of female sexual dysfunctions. Rev Psiq Clín 2006;33:162–7
   Google Scholar
• Moreira ED Jr, Abdo CH, Torres EB, Lôbo CF, Fittipaldi JA. Prevalence and correlates of erectile dysfunction: results of the Brazilian study of sexual behavior. Urology 2001;58:583–8
   PubMed Web of Science ®Google Scholar
• Leite APL, Moura EA, Campos AAS, Mattar R, Souza E, Camano L. Validation of the Female Sexual Function Index in Brazilian pregnant women. Rev Bras Ginecol Obstet 2007;29:396–401
   Google Scholar
• Abdo CH, Oliveira WMJR, Moreira EDJR, Fittipaldi JA. Prevalence of sexual dysfunctions and correlated conditions in a sample of Brazilian women – results of the Brazilian study on sexual behavior (BSSB). Int J Impot Res 2004;16:160–6
   PubMed Web of Science ®Google Scholar
• Bovenberg SA, Van Uum SH, Hermus AR. Dehydroepiandrosterone administration in humans: evidence based? Neth J Med 2005;63:300–4
   PubMed Web of Science ®Google Scholar
• Yadida G, Sudaia E, Maayanb R, Gispana I, Weizman A. The role of dehydroepiandrosterone (DHEA) in drug-seeking behavior. Neurosci Biobehav Rev 2010;35:303–14
   PubMed Web of Science ®Google Scholar
• Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol 2009;30:65–91
   PubMed Web of Science ®Google Scholar
• Speroff L, Glass RH, Kase NG. O ovário desde a concepção até a senilidade. In: Speroff L, Glass RH, Kase NG, eds. Endocrinologia Ginecológica Clínica e Infertilidade. 5th edn. São Paulo: Manole, 1995
   Google Scholar
• Wajchenberg BL. Tratado de Endocrinologia Clínica. São Paulo: Roca, 1992
   Google Scholar
• Wolkowitz OM, Rothschild AJ. Psychoneuroendocrinology: The Scientific Basis of Clinical Practice. Washington (DC): American Psychiatric Publishing Inc, 2003
   Google Scholar
• Arlt W, Callies F, Allolio B. DHEA replacement in women with adrenal insufficiency pharmacokinetics. Bioconversion and clinical effects on well-being, sexuality and cognition. Endocrine Kesear 2000;26:505–11
   Web of Science ®Google Scholar
• Peixoto C, Cheda JND, Nardi AE, Veras AB, Cardoso A. The effects of dehydroepiandrosterone (DHEA) in the treatment of depression and depressive symptoms in other psychiatric and medical illnesses: a systematic review. Curr Drug Targets 2014;15:901–14
   PubMed Web of Science ®Google Scholar
• Menezes JK, Peixoto C, Nardi AE, Carta MG, Machado S, Veras AB. Dehydroepiandrosterone, its sulfate and cognitive functions. Clin Pract Epidemiol Ment Health 2016;12:24–37
   PubMedGoogle Scholar
• Bloch M, Ish-Shalom S, Greenman Y, Klein E, Latzer Y. Dehydroepiandrosterone treatment effects on weight, bone density, bone metabolism and mood in women suffering from anorexia nervosa – a pilot study. Psychiatry Res 2012;200:544–9
   PubMed Web of Science ®Google Scholar
• Hartkamp A, Geenen R, Godaert GLR, et al. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial. Ann Rheum Dis 2008;67:91–7
   PubMed Web of Science ®Google Scholar
• Hartkamp A, Geenen R, Godaert GLR, Bijl M, Bijlsma JWJ, Derksen RHWM. Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial. Ann Rheum Dis 2010;69:1144–7
   PubMed Web of Science ®Google Scholar
• Bradley M, Mcelhiney M, Rabikin J. DHEA and cognition in HIV-positive patients with non-major depression. Psychosomatics 2012;53:244–9
   PubMed Web of Science ®Google Scholar
• Bouchard C, Labrie F, Derogatis L, et al. Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study. Horm Mol Biol Clin Investig 2016;25:181–90
   PubMed Web of Science ®Google Scholar
• Labrie F, Archer DF, Koltun W, et al. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause 2016;23:243–56
   PubMed Web of Science ®Google Scholar
• Archer DF, Labrie F, Bouchard C, et al. Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone). Menopause 2015;22:950–63
   PubMed Web of Science ®Google Scholar
• Labrie F, Derogatis L, Archer DF, et al. Effect of intravaginal prasterone on sexual dysfunction in postmenopausal women with vulvovaginal atrophy. J Sex Med 2015;12:2401–12
   PubMed Web of Science ®Google Scholar
• Labrie F, Montesino M, Archer DF, et al. Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner. Climacteric 2015;18:817–25
   PubMed Web of Science ®Google Scholar
• Labrie F, Archer DF, Bouchard C, et al. Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. Maturitas 2015;81:46–56
   PubMed Web of Science ®Google Scholar
• Labrie F, Archer D, Bouchard C, et al. Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women. J Sex Med 2014;11:1766–85
   PubMed Web of Science ®Google Scholar
• Bloch M, Meiboom H, Zaig I, Schreiber S, Abramov L. The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: a report of gender differences. Eur Neuropsychopharmacol 2013;23:910–18
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Stomati M, Valentino V, et al. Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality. Climacteric 2011;14:661–8
   PubMed Web of Science ®Google Scholar
• Labrie F, Archer DF, Bouchard C, et al. Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia. Climacteric 2011;14:282–8
   PubMed Web of Science ®Google Scholar
• Labrie F, Archer D, Bouchard C, et al. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause 2009;16:923–31
   PubMed Web of Science ®Google Scholar
• Brooke AM, Kalingag LA, Miraki-Moud F, et al. Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement. J Clin Endocrinol Metab 2006;91:3773–9
   PubMed Web of Science ®Google Scholar
• Nordmark G, Bengtsson C, Larsson A, Karlsson FA, Sturfelt G, Rönnblom L. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus. Autoimmunity 2005;38:531–40
   PubMed Web of Science ®Google Scholar
• Hackbert L, Heiman JR. Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women. J Womens Health Gend Based Med 2002;11:155–62
   PubMedGoogle Scholar
• Munarriz R, Talakoub L, Flaherty E, et al. Androgen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction: androgen and questionnaire results. J Sex Marital Ther 2002;28:165–73
   PubMed Web of Science ®Google Scholar
• Guay AT. Decreased testosterone in regularly menstruating women with decreased libido: a clinical observation. J Sex Marital Ther 2001;27:513–39
   PubMed Web of Science ®Google Scholar
• Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHE Age Study to a sociobiomedical issue. Proc Natl Acad Sci USA 2000;97:4279–84
   PubMed Web of Science ®Google Scholar
• Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999;341:1013–20
   PubMed Web of Science ®Google Scholar
• Himmel PB, Seligman TMA. Pilot study employing dehydroepiandrosterone (DHEA) in the treatment of chronic fatigue syndrome. J Clin Rheumatol 1999;5:56–9
   PubMed Web of Science ®Google Scholar
• Reiter WJ, Pycha A, Schatzl G, et al. Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study. Urology 1999;53:590–5
   PubMed Web of Science ®Google Scholar
• Morales A, Black A, Emerson L, Barkin J, Kuzmarov I, Day A. Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency. Aging Male 2009;12:104–12
   PubMed Web of Science ®Google Scholar
• Panjari M, Bell RJ, Jane F, et al. A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido. J Sex Med 2009;6:2579–90
   PubMed Web of Science ®Google Scholar
• Kritz-Silverstein D, Von Mühlen D, Laughlin GA, Bettencourt R. Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well-Ness (DAWN) Trial. J Am Geriatr Soc 2008;56:1292–8
   PubMed Web of Science ®Google Scholar
• Finckh A, Berner IC, Aubry-Rozier B, So AK. A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia. J Rheumatol 2005;32:1336–40
   PubMed Web of Science ®Google Scholar
• van Thiel SW, Romijn JA, Pereira AM, et al. Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial. J Clin Endocrinol Metab 2005;90:3295–303
   PubMed Web of Science ®Google Scholar
• Løvås K, Gebre-Medhin G, Trovik TS, et al. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 2003;88:1112–18
   PubMed Web of Science ®Google Scholar
• Meston CM, Heiman JR. Acute dehydroepiandrosterone effects on sexual arousal in premenopausal women. J Sex Marital Ther 2002;28:53–60
   PubMed Web of Science ®Google Scholar
• Arlt W, Callies F, Koehler I, et al. Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion. J Clin Endocrinol Metab 2001;86:4686–92
   PubMed Web of Science ®Google Scholar
• Hunt PJ, Gurnell EM, Huppert FA, et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 2000;85:4650–6
   PubMed Web of Science ®Google Scholar
• Barnhart KT, Freeman E, Grisso JA, et al. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 1999;84:3896–902
   PubMed Web of Science ®Google Scholar
• Flynn MA, Weaver-Osterholtz D, Sharpe-Timms KL, Allen S, Krause G. Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab 1999;84:1527–33
   PubMed Web of Science ®Google Scholar
• Wallace MB, Lim J, Cutler A, Bucci L. Effects of dehydroepiandrosterone vs androstenedione supplementation in men. Med Sci Sports Exerc 1999;31:1788–92
   PubMed Web of Science ®Google Scholar
• Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360–7
   PubMed Web of Science ®Google Scholar
• Zimmerman Y, Foidart JM, Pintiaux A, et al. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive. II. Clinical effects. Contraception 2015;91:134–42
   PubMed Web of Science ®Google Scholar
• Labrie F, Archer D, Bouchard C, et al. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause 2009;16:897–906
   PubMed Web of Science ®Google Scholar
• Libè R, Barbetta L, Dall’Asta C, et al. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism. J Endocrinol Invest 2004;27:736–41
   PubMed Web of Science ®Google Scholar
• Johannsson G, Burman P, Wirén L, et al. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. J Clin Endocrinol Metab 2002;87:2046–52
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Ferrando SJ, Wagner GJ, Rabkin R. DHEA treatment for HIV + patients: effects on mood, androgenic and anabolic parameters. Psychoneuroendocrinology 2000;25:53–68
   PubMed Web of Science ®Google Scholar
• Nadjafi-Triebsch C, Huell M, Burki D, Rohr UD. Progesterone increase under DHEA-substitution in males. Maturitas 2003;45:231–5
   PubMed Web of Science ®Google Scholar
• Gannon JR, Walsh TJ. Testosterone and sexual function. Urol Clin North Am 2016;43:217–22
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. FDA approves Intrarosa for postmenopausal women experiencing pain during sex. Published by FDA, November 17, 2016. Accessed in 12-20-2016. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm529641.htm
   Google Scholar